FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377013013> ?p ?o ?g. }

• W4377013013 endingPage "104053" @default.
• W4377013013 startingPage "104053" @default.
• W4377013013 abstract "Australian prescription drug monitoring programs (PDMPs) provide information about a patient's recent medication history for controlled drugs at the point of prescribing and dispensing. Despite their increasing use, the evidence for PDMPs is mixed, and is almost exclusively from the United States. This study examined the impact of PDMP implementation on opioid prescribing among general practitioners in Victoria, Australia. We examined data on analgesic prescribing using electronic records of 464 medical practices in the Australian state of Victoria between 01/04/2017 and 31/12/ 2020. We used interrupted time series analyses, to examine immediate and longer-term trends in medication prescribing following voluntary (from April 2019) and mandatory PDMP implementation (from April 2020). We examined changes in three outcomes (i) ‘high’ opioid dose (50-100mg oral morphine equivalent daily dose (OMEDD) and over 100mg (OMEDD) prescribing (ii) prescribing of high-risk medication combinations (opioids with either benzodiazepines or pregabalin), and (iii) initiation of non-controlled pain medications (tricyclic antidepressants, pregabalin and tramadol). We found no effect of voluntary or mandatory PDMP implementation on ‘high-dose’ opioid prescribing with reductions only seen in those prescribed <20mg OMEDD (i.e., the lowest dose category). Co-prescribing of opioids with benzodiazepines (additional 11.87 [95%CI 2.04 to 21.67] patients/10,000 and pregabalin (additional 3.54 [95% CI 0.82 to 6.26] patients/10,000 increased following mandatory PDMP implementation among those prescribed opioids. In contrast to trends of reduced initiation prior to PDMP implementation, we found increased new initiation of non-monitored medications following PDMP implementation (e.g., an immediate increase of 2.32 [95%CI 0.02 to 4.54], patients/10,000 received pregabalin and 3.06 [95%CI 0.54 to 5.5] patients/10,000 received tricyclic antidepressants after mandatory PDMP implementation), and increased tramadol initiation during the voluntary PDMP period (an increase of 11.26 [95%CI: 5.84, 16.67] patients /10,000). PDMP implementation did not appear to reduce prescribing of high opioid doses or high-risk combinations. Increased initiation of tricyclic antidepressants, pregabalin and tramadol may indicate a possible unintended effect." @default.
• W4377013013 created "2023-05-19" @default.
• W4377013013 creator A5009878087 @default.
• W4377013013 creator A5028372253 @default.
• W4377013013 creator A5030500693 @default.
• W4377013013 creator A5035523410 @default.
• W4377013013 creator A5049259783 @default.
• W4377013013 creator A5056532577 @default.
• W4377013013 creator A5063428081 @default.
• W4377013013 creator A5070677344 @default.
• W4377013013 creator A5084523298 @default.
• W4377013013 date "2023-07-01" @default.
• W4377013013 modified "2023-10-14" @default.
• W4377013013 title "Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes" @default.
• W4377013013 cites W1557920062 @default.
• W4377013013 cites W1577188990 @default.
• W4377013013 cites W1972850166 @default.
• W4377013013 cites W1985281481 @default.
• W4377013013 cites W2013341595 @default.
• W4377013013 cites W2016817238 @default.
• W4377013013 cites W2022835494 @default.
• W4377013013 cites W2040696505 @default.
• W4377013013 cites W2123873061 @default.
• W4377013013 cites W2233361447 @default.
• W4377013013 cites W2300421333 @default.
• W4377013013 cites W2713013495 @default.
• W4377013013 cites W2739913519 @default.
• W4377013013 cites W2740244424 @default.
• W4377013013 cites W2751065906 @default.
• W4377013013 cites W2760847338 @default.
• W4377013013 cites W2800278321 @default.
• W4377013013 cites W2807338261 @default.
• W4377013013 cites W2895896590 @default.
• W4377013013 cites W2900742318 @default.
• W4377013013 cites W2904176856 @default.
• W4377013013 cites W2905366501 @default.
• W4377013013 cites W2913254672 @default.
• W4377013013 cites W2913621448 @default.
• W4377013013 cites W2942632282 @default.
• W4377013013 cites W2970745849 @default.
• W4377013013 cites W2971934297 @default.
• W4377013013 cites W2982015067 @default.
• W4377013013 cites W2988262664 @default.
• W4377013013 cites W3009147246 @default.
• W4377013013 cites W3014920334 @default.
• W4377013013 cites W3101898279 @default.
• W4377013013 cites W3110191235 @default.
• W4377013013 cites W3117516303 @default.
• W4377013013 cites W3126362147 @default.
• W4377013013 cites W3130918945 @default.
• W4377013013 cites W3152368521 @default.
• W4377013013 cites W3200746904 @default.
• W4377013013 cites W3212309175 @default.
• W4377013013 cites W3212675472 @default.
• W4377013013 cites W4205877800 @default.
• W4377013013 cites W4220814322 @default.
• W4377013013 cites W4237934936 @default.
• W4377013013 cites W4282587939 @default.
• W4377013013 cites W4296615556 @default.
• W4377013013 cites W4307430513 @default.
• W4377013013 cites W4312065201 @default.
• W4377013013 cites W647573108 @default.
• W4377013013 doi "https://doi.org/10.1016/j.drugpo.2023.104053" @default.
• W4377013013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37209441" @default.
• W4377013013 hasPublicationYear "2023" @default.
• W4377013013 type Work @default.
• W4377013013 citedByCount "2" @default.
• W4377013013 countsByYear W43770130132023 @default.
• W4377013013 crossrefType "journal-article" @default.
• W4377013013 hasAuthorship W4377013013A5009878087 @default.
• W4377013013 hasAuthorship W4377013013A5028372253 @default.
• W4377013013 hasAuthorship W4377013013A5030500693 @default.
• W4377013013 hasAuthorship W4377013013A5035523410 @default.
• W4377013013 hasAuthorship W4377013013A5049259783 @default.
• W4377013013 hasAuthorship W4377013013A5056532577 @default.
• W4377013013 hasAuthorship W4377013013A5063428081 @default.
• W4377013013 hasAuthorship W4377013013A5070677344 @default.
• W4377013013 hasAuthorship W4377013013A5084523298 @default.
• W4377013013 hasBestOaLocation W43770130131 @default.
• W4377013013 hasConcept C105795698 @default.
• W4377013013 hasConcept C126322002 @default.
• W4377013013 hasConcept C170493617 @default.
• W4377013013 hasConcept C194828623 @default.
• W4377013013 hasConcept C2426938 @default.
• W4377013013 hasConcept C2776468701 @default.
• W4377013013 hasConcept C2777972796 @default.
• W4377013013 hasConcept C2779418921 @default.
• W4377013013 hasConcept C2779777798 @default.
• W4377013013 hasConcept C2780820201 @default.
• W4377013013 hasConcept C2781063702 @default.
• W4377013013 hasConcept C2909024267 @default.
• W4377013013 hasConcept C2911204551 @default.
• W4377013013 hasConcept C33923547 @default.
• W4377013013 hasConcept C42219234 @default.
• W4377013013 hasConcept C71924100 @default.
• W4377013013 hasConcept C98274493 @default.
• W4377013013 hasConceptScore W4377013013C105795698 @default.
• W4377013013 hasConceptScore W4377013013C126322002 @default.

• next